Biopharma News

Dec 08, 2014
BioPharm International
The acquisition will enhance Merck's "superbug" medication portfolio.
Dec 08, 2014
By BioPharm International Editors
Under an NIH contract, Paragon Bioservices will design a manufacturing process for recombinant human rhE-selectin protein.
Dec 04, 2014
BioPharm International
Amgen's bispecific T-cell engager (BiTE) antibody constructs help the body fight malignant cancer cells.
Dec 04, 2014
BioPharm International
Sanofi executives are being charged in a whistleblower lawsuit for allegedly granting illicit payments to healthcare providers.
Dec 03, 2014
BioPharm International
CytRx receives formal written communication from FDA on a prior decision for a partial clinical hold for CytRx's trials involving chemotherapeutic agent aldoxorubicin.
Dec 02, 2014
BioPharm International
By BioPharm International Editors
Roche announced the acquisition of Ariosa Diagnostics, a molecular diagnostics testing service provider and maker of the prenatal blood test, Harmony.
Dec 02, 2014
BioPharm International
By BioPharm International Editors
Lung Therapeutics announced that it received Orphan Drug Designation for LTI-01, an injectable designed for the treatment of loculated pleural effusion.
Dec 02, 2014
BioPharm International
Ranbaxy and Epirus announce the launch of India's first biosimilar for Remicade.
Dec 02, 2014
BioPharm International
By BioPharm International Editors
Japanese drugmaker Otsuka announced plans to buy CNS-specialist Avanir Pharmaceuticals for $3.5 billion in an all-cash tender offer.
Dec 01, 2014
BioPharm International
By BioPharm International Editors
Medtronic announced that it received clearance from both the FTC and European Commission to acquire Covidien for $43 billion.
native1_300x100
lorem ipsum